One-week dextran sulfate treatment of conventional (CV) immunodeficient (SCID) mice gave rise to acute colitis in the colon mucosa; germ-free (GF) SCID mice did not exhibit any changes in colon morphology. Dextran sulfate application to CV immunocompetent (BALB/c) mice did induce substantial changes in the colon mucosa (grade 4); GF BALB/c mice showed mild changes in the colon morphology (grade 1) only. GF SCID mice and CV SCID mice died during the second round of dextran sulfate treatment suffering from chronic colitis; GF BALB/c mice exhibited mild crypt distortion while CV BALB/c mice showed a complete loss of the surface epithelium (grade 4), accompanied by T and B lymphocyte infiltration.

Department of Immunology and Gnotobiology Institute of Microbiology Academy of Sciences of the Czech Republic 549 22 Nový Hrádek Czechia

See more in PubMed

Eur J Gastroenterol Hepatol. 2000 Mar;12(3):267-73 PubMed

Nihon Shokakibyo Gakkai Zasshi. 1985 May;82(5):1327-36 PubMed

Gut. 2000 Jan;46(1):64-72 PubMed

Folia Microbiol (Praha). 1998;43(5):531-4 PubMed

Scand J Immunol. 1997 Dec;46(6):581-6 PubMed

Cell. 1993 Oct 22;75(2):203-5 PubMed

Ther Immunol. 1995 Apr;2(2):115-23 PubMed

Toxicol Pathol. 1999 Jan-Feb;27(1):123-33 PubMed

Folia Microbiol (Praha). 1998;43(5):545-50 PubMed

Ann N Y Acad Sci. 1983 Jun 30;409:96-113 PubMed

Lab Invest. 1993 Aug;69(2):238-49 PubMed

Gut. 1996 Aug;39(2):234-41 PubMed

Ann N Y Acad Sci. 1998 Nov 17;859:85-95 PubMed

Acta Gastroenterol Belg. 1994 Sep-Dec;57(5-6):306-9 PubMed

Acta Gastroenterol Belg. 1997 Apr-Jun;60(2):163-5 PubMed

Gastroenterology. 1990 Mar;98(3):694-702 PubMed

Clin Exp Immunol. 2000 Apr;120(1):46-50 PubMed

Gut. 2000 Jan;46(1):73-7 PubMed

Annu Rev Immunol. 1991;9:323-50 PubMed

Immunol Today. 1985 Apr;6(4):131-6 PubMed

Gut. 1971 Feb;12(2):164-71 PubMed

Gastroenterology. 1994 Dec;107(6):1643-52 PubMed

Priority order of neonatal colonization by a probiotic or pathogenic Escherichia coli strain dictates the host response to experimental colitis

The effect of oral butyrate on colonic short-chain fatty acid transporters and receptors depends on microbial status

Effect of DSS-Induced Ulcerative Colitis and Butyrate on the Cytochrome P450 2A5: Contribution of the Microbiome

Butyrate Treatment of DSS-Induced Ulcerative Colitis Affects the Hepatic Drug Metabolism in Mice

Spontaneous and Induced Tumors in Germ-Free Animals: A General Review

Innovative Animal Model of DSS-Induced Ulcerative Colitis in Pseudo Germ-Free Mice

Diet Rich in Animal Protein Promotes Pro-inflammatory Macrophage Response and Exacerbates Colitis in Mice

The Microbiota Determines Susceptibility to Experimental Autoimmune Uveoretinitis

Development of gut inflammation in mice colonized with mucosa-associated bacteria from patients with ulcerative colitis

Bifidobacterium longum CCM 7952 Promotes Epithelial Barrier Function and Prevents Acute DSS-Induced Colitis in Strictly Strain-Specific Manner

Protective effect of Clostridium tyrobutyricum in acute dextran sodium sulphate-induced colitis: differential regulation of tumour necrosis factor-α and interleukin-18 in BALB/c and severe combined immunodeficiency mice

Lysate of probiotic Lactobacillus casei DN-114 001 ameliorates colitis by strengthening the gut barrier function and changing the gut microenvironment

The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases

Oral administration of Parabacteroides distasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition

Detection of galectin-3 in patients with inflammatory bowel diseases: new serum marker of active forms of IBD?

Intestinal microbiota in exclusively breast-fed infants with blood-streaked stools

Expression of Toll-like receptor 2 (TLR2), TLR4, and CD14 in biopsy samples of patients with inflammatory bowel diseases: upregulated expression of TLR2 in terminal ileum of patients with ulcerative colitis

Effects of monocolonization with Escherichia coli strains O6K13 and Nissle 1917 on the development of experimentally induced acute and chronic intestinal inflammation in germ-free immunocompetent and immunodeficient mice

Oral administration of probiotic bacteria (E. coli Nissle, E. coli O83, Lactobacillus casei) influences the severity of dextran sodium sulfate-induced colitis in BALB/c mice

Experimental colitis does not increase the prevalence of ANKENT, a spontaneous joint disease in mice